PT - JOURNAL ARTICLE AU - Josalyn L. Cho AU - Raul Villacreses AU - Prashant Nagpal AU - Junfeng Guo AU - Alejandro A. Pezzulo AU - Andrew L. Thurman AU - Nabeel Y. Hamzeh AU - Robert J. Blount AU - Spyridon Fortis AU - Eric A. Hoffman AU - Joseph Zabner AU - Alejandro P. Comellas TI - Small Airways Disease is a Post-Acute Sequelae of SARS-CoV-2 Infection AID - 10.1101/2021.05.27.21257944 DP - 2021 Jan 01 TA - medRxiv PG - 2021.05.27.21257944 4099 - http://medrxiv.org/content/early/2021/05/30/2021.05.27.21257944.short 4100 - http://medrxiv.org/content/early/2021/05/30/2021.05.27.21257944.full AB - Background The sequelae of SARS-CoV-2 infection on pulmonary structure and function remain incompletely characterized.Methods Adults with confirmed COVID-19 who remained symptomatic more than thirty days following diagnosis were enrolled and classified as ambulatory, hospitalized or requiring the intensive care unit (ICU) based on the highest level of care received during acute infection. Symptoms, pulmonary function tests and chest computed tomography (CT) findings were compared across groups and to healthy controls. CT images were quantitatively analyzed using supervised machine-learning to measure regional ground glass opacities (GGO) and image-matching to measure regional air trapping. Comparisons were performed using univariate analyses and multivariate linear regression.Results Of the 100 patients enrolled, 67 were in the ambulatory group. All groups commonly reported cough and dyspnea. Pulmonary function testing revealed restrictive physiology in the hospitalized and ICU groups but was normal in the ambulatory group. Among hospitalized and ICU patients, the mean percent of total lung classified as GGO was 13.2% and 28.7%, respectively, and was higher than in ambulatory patients (3.7%, P<0.001). The mean percentage of total lung affected by air trapping was 25.4%, 34.5% and 27.2% in the ambulatory, hospitalized and ICU groups and 7.3% in healthy controls (P<0.001). Air trapping measured by quantitative CT correlated with the residual volume to total lung capacity ratio (RV/TLC; ρ=0.6, P<0.001).Conclusions Air trapping is present in patients with post-acute sequelae of COVID-19 and is independent of initial infection severity, suggesting obstruction at the level of the small airways. The long-term consequences are not known.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis was not a clinical trial and just an observational cohortFunding StatementThis work was supported by grants from the National Institutes of Health (R01HL112986 and S10OD018526 to EAH; R01HL136813, P01HL152960, P01HL091842, P30DK054759 and T32HL007638 to JZ).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the institutional review board of the University of Iowa. The authors analyzed only de-identified data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe individual participant data that underlie the results reported in this Article, as well as the statistical analysis plan, will be made available after deidentification. Researchers who provide a methodologically sound proposal for any purpose may direct proposals to alejandro-comellas@uiowa.edu. To gain access, data requestors will need to sign a data access agreement that requires approval by University of Iowa Office of Technology Transfer.